Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
29.90
-1.44 (-4.59%)
Last updated: Jun 6, 2025
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 11.04 billion as of June 6, 2025. Its market cap has decreased by -27.87% in one year.
Market Cap
11.04B
Enterprise Value
9.56B
Revenue
50.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.90
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 11.04B, a decrease of -11.46%. That is a compound annual growth rate of -6.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 6, 2025 | 11.04B | 20.05% |
Dec 31, 2024 | 9.20B | -37.20% |
Dec 29, 2023 | 14.65B | 17.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 356.59B |
Shenzhen Mindray Bio-Medical Electronics | 281.18B |
WuXi AppTec | 183.32B |
Zhangzhou Pientzehuang Pharmaceutical., | 122.35B |
Sichuan Biokin Pharmaceutical | 120.95B |
Aier Eye Hospital Group | 116.45B |
Shanghai United Imaging Healthcare | 110.01B |
Yunnan Baiyao Group Co.,Ltd | 100.99B |